Medical treatment of neuroendocrine tumors

Timothy J. Hobday

doi:10.1007/978-1-4419-1069-1_28

Medical treatment of neuroendocrine tumors

Timothy J. Hobday

Medical Oncology

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

The management of gastrointestinal neuroendocrine tumors takes into consideration the clinical stage of the disease, any symptoms from disease bulk or hormone overproduction, and the clinical pace of the disease. Options for therapy include observation, octreotide to reduce hormonal secretion, or other more toxic therapies such as interferon-α, chemotherapy, or molecularly targeted therapies under investigation. Surgery or embolic therapy to branches of the hepatic artery may also assist in the management of these patients.

Original language	English (US)
Title of host publication	Endocrine Pathology
Subtitle of host publication	Differential Diagnosis and Molecular Advances
Publisher	Springer New York
Pages	561-566
Number of pages	6
ISBN (Print)	9781441910684
DOIs	https://doi.org/10.1007/978-1-4419-1069-1_28
State	Published - 2010

Keywords

Carcinoid tumor
Chemotherapy
Islet cell carcinoma
Octreotide
Targeted therapy

ASJC Scopus subject areas

General Medicine

Access to Document

10.1007/978-1-4419-1069-1_28

Cite this

@inbook{7c9d91ddc9ce4866a8c93f2b380df36c,

title = "Medical treatment of neuroendocrine tumors",

abstract = "The management of gastrointestinal neuroendocrine tumors takes into consideration the clinical stage of the disease, any symptoms from disease bulk or hormone overproduction, and the clinical pace of the disease. Options for therapy include observation, octreotide to reduce hormonal secretion, or other more toxic therapies such as interferon-α, chemotherapy, or molecularly targeted therapies under investigation. Surgery or embolic therapy to branches of the hepatic artery may also assist in the management of these patients.",

keywords = "Carcinoid tumor, Chemotherapy, Islet cell carcinoma, Octreotide, Targeted therapy",

author = "Hobday, {Timothy J.}",

year = "2010",

doi = "10.1007/978-1-4419-1069-1_28",

language = "English (US)",

isbn = "9781441910684",

pages = "561--566",

booktitle = "Endocrine Pathology",

publisher = "Springer New York",

}

TY - CHAP

T1 - Medical treatment of neuroendocrine tumors

AU - Hobday, Timothy J.

PY - 2010

Y1 - 2010

N2 - The management of gastrointestinal neuroendocrine tumors takes into consideration the clinical stage of the disease, any symptoms from disease bulk or hormone overproduction, and the clinical pace of the disease. Options for therapy include observation, octreotide to reduce hormonal secretion, or other more toxic therapies such as interferon-α, chemotherapy, or molecularly targeted therapies under investigation. Surgery or embolic therapy to branches of the hepatic artery may also assist in the management of these patients.

AB - The management of gastrointestinal neuroendocrine tumors takes into consideration the clinical stage of the disease, any symptoms from disease bulk or hormone overproduction, and the clinical pace of the disease. Options for therapy include observation, octreotide to reduce hormonal secretion, or other more toxic therapies such as interferon-α, chemotherapy, or molecularly targeted therapies under investigation. Surgery or embolic therapy to branches of the hepatic artery may also assist in the management of these patients.

KW - Carcinoid tumor

KW - Chemotherapy

KW - Islet cell carcinoma

KW - Octreotide

KW - Targeted therapy

UR - http://www.scopus.com/inward/record.url?scp=84890196817&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890196817&partnerID=8YFLogxK

U2 - 10.1007/978-1-4419-1069-1_28

DO - 10.1007/978-1-4419-1069-1_28

M3 - Chapter

AN - SCOPUS:84890196817

SN - 9781441910684

SP - 561

EP - 566

BT - Endocrine Pathology

PB - Springer New York

ER -

Medical treatment of neuroendocrine tumors

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this